Episode 36: Being Transparent About Clinical Trial Transparency
Clinical trial transparency is a delicate balance of getting the right data to the right resources at the right time. Senior Partner Lisa Chamberlain James sits down with the President of Holtzople Consulting, Julie Holtzople, to discuss how to do just that. They discuss standardizing information for researchers, building trust, advice for best practices, and whether all this transparency is legally mandated – or simply the right thing to do.
--------
24:26
--------
24:26
Episode 35: Introducing the AMWA Apprentice Program Framework – A step-by-step guide to training medical writers
The demand for experienced medical writers is outpacing the availability of experienced writers. In TriloTalk episode 35, Julia Forjanic Klapproth, Senior Partner at Trilogy, and Kim Jochman, Senior Director of Medical Writing at Merck, raise awareness of two new essential AMWA resources: the apprentice program framework and the job leveling framework. As members of the workstreams who developed these, Julia and Kim bring insights and the rationale from behind the scenes. Tune in and learn about these important initiatives for the medical writing community.
--------
32:15
--------
32:15
Episode 34: AI Agents - the future that's being used today!
For episode 34 of the TriloTalk podcast, Lisa Chamberlain James, Senior Partner at Trilogy, sits down with the AI Agent expert Nikesh Shah, VP and Global Head, Generative AI at Indegene. They discuss everything you need to know about AI Agents – the day-to-day usage, project confidentiality, when it will become mainstream, which industries are using it now, and how it will enrich our lives. It's an episode you don’t want to miss!
--------
27:41
--------
27:41
Episode 33: Are Medical Devices from Venus and Pharmaceuticals from Mars? Important things to know when writing for medical devices.
This episode focuses on writing for medical devices. Playing Sherlock Holmes, conducting usability studies, following regulations, working closely with the manufacturers and much more are all in a day's work when writing for devices. Listen to Trilogy's medical writing managers, Heidi Chapman and Laura Collada, and Senior Partner, Julia Forjanic Klapproth, discuss the similarities and differences between writing for devices and writing for drugs. Listen up!
--------
28:01
--------
28:01
Episode 32: Engaging the Clinical Trial Participant – using Plain Language in Informed Consent Forms
The Informed Consent Form is a participant’s first impression of a clinical trial so Lisa Chamberlain James and Ros Cheetham sit down to discuss how to make it the best it can be. Learn about the layout, formatting, crafting tips, where plain language fits in, and its future.
Conversations to bring medical writing topics to the forefront and hopefully spark wider conversations in the domain of medical writing. TriloTalk episodes will range from the value of medical writing to apprenticeship. TriloTalk will also cover document-specific topics such as lay summaries and how to tame CTD dossiers.
Sverige